Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.
about
New virologic tools for management of chronic hepatitis B and CUsefulness of the Hepatitis C Virus Core Antigen Assay for Screening of a Population Undergoing Routine Medical CheckupSimultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV InfectionEstablishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals.Laboratory Assays for Diagnosis and Management of Hepatitis C Virus InfectionComparative Evaluation of the Total Hepatitis C Virus Core Antigen, Branched-DNA, and Amplicor Monitor Assays in Determining Viremia for Patients with Chronic Hepatitis C during Interferon Plus Ribavirin Combination TherapyMonitoring Response to Antiviral Therapy for Patients with Chronic Hepatitis C Virus Infection by a Core-Antigen AssayHepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissectionQuantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulinsAssessment of Specific Antibodies to F Protein in Serum Samples from Chinese Hepatitis C Patients Treated with Interferon plus RibavarinDifferential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic CellsEvaluation of Hepatitis C Virus Core Antigen Assays in Detecting Recombinant Viral Antigens of Various GenotypesRole of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular DamageAnalytical Performance Characteristics and Clinical Utility of a Novel Assay for Total Hepatitis C Virus Core Antigen QuantificationHepatitis C virus infection.Hepatitis C treatment: where are we now?Diagnostic tests for hepatitis C: recent trends in electrochemical immunosensor and genosensor analysis.Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt.Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay.Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapyNovel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patientsVariable ratio of hepatitis C virus RNA to viral core antigen in patient sera.Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemiaA higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patientsHepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patientsEvaluation of an antigen-antibody "combination" enzyme linked immunosorbent assay for diagnosis of hepatitis C virus infections.Use and interpretation of virological tests for hepatitis C.Kinetics and significance of serum hepatitis C virus core antigen in patients with acute hepatitis CInhibition of hepatitis C virus production by aptamers against the core protein.Comparison of HCV core antigen and anti-HCV with HCV RNA results.Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease.Hepatitis C virus RNA tests: performance attributes and their impact on clinical utility.Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV resultsStrong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patientsDetection of hepatitis C virus core antigen in blood donors using a new enzyme immunoassay.Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy.Chronic viral hepatitis in hemodialysis patients.Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples
P2860
Q27026914-EBD5E5F7-78D0-4C25-92D6-4D5EAFD13890Q27469465-2541D3BD-286E-495C-9472-6254984C2AE1Q27471998-D5E77CB1-FA20-45AB-9DC6-1B937BA52F52Q27473088-00F9A3B7-0346-462D-85C3-497F058AA976Q27473162-DAA71C94-4B7A-4398-9BF4-E7CC166AE82CQ27473492-C5697DAE-89EA-416E-B6A7-F1756EFC2EC8Q27477674-EC40992C-D602-467D-9C3A-67ACAFF5000DQ27478083-3F6A70CB-0A9D-44F2-B36A-92E12CF51780Q27478121-9E93A71A-9916-49C4-ABCC-45F05A80EA70Q27480975-D642FF43-6BB6-4715-B82A-399A2414A4FAQ27487302-3060F53E-81A6-4E2D-8893-77F4D5D94AEEQ27488392-E8E8BD6E-4734-4F56-A10E-8D51E9752999Q27490457-CB3C88D3-6458-42B3-BA93-E775184106AFQ27490515-06FB8787-258C-4047-92D1-EB8069BDE467Q27491329-9F1F3AA7-FDD8-4775-ACCB-0600E5E4DF31Q30235491-8D2912B5-C7A5-4ED5-92F6-D48ABF68128EQ30378509-29DF7505-4C35-452A-BFD2-3959A1A40343Q30426257-DA668509-2915-4ECB-A5AE-205130A154DAQ30433630-DBED30A1-AEBB-461C-8F6B-A13CBE9D2BE0Q33197019-FFC49DAD-B6AD-45C8-8159-577F539F852DQ33592250-71471FBA-0950-4680-91E2-2B803CF9D07BQ33592762-A7BDD925-949D-4FBD-A922-4824D51222C3Q33712801-E47443E2-C015-4201-BC74-80C5892F673FQ33766292-3550743C-5D3B-4FBA-9507-EA5B534B10F3Q33999798-4A2B2309-A809-4324-9545-944166BA7404Q34008754-98D56D03-F82A-4CD6-B19E-16A64D3E9FE1Q34475736-A1218B0D-A25C-4118-921C-733D4947EE5DQ34588996-A41E1296-920F-4BD8-8214-9949205B5F83Q34984049-4311C4DB-F9C8-47E5-AC60-FB85A0B8A7F1Q34991008-BF8B09FB-526E-4A94-BA79-E89B61D356DFQ35059404-B7C1FEC4-DD54-4439-91E9-D5212BCDC5B1Q35207132-31A54976-DBEE-4E64-B415-3021B25BACC3Q35237341-1205A555-FC1A-475A-BB8A-C20B426BB1AAQ35589284-96B9D29A-1696-4E21-9EC5-DEE87509D51AQ35599069-94C14318-20CF-480A-8E0A-1EB43A191890Q35689119-87D188C4-AC44-4481-860D-A2E8DC93A22AQ36133920-096EA160-1BCB-46E8-B9C7-8F9CE9F3C2EBQ36258800-FA7B4A80-11AD-429A-BE77-4451CBF15179Q36271099-B2BD1031-FEEC-4B47-9937-DD40098E4F03Q36554189-763AF07F-5AFE-4866-9EB1-61310AAE8A82
P2860
Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Clinical utility of total HCV ...... ect marker of HCV replication.
@en
Clinical utility of total HCV ...... ect marker of HCV replication.
@nl
type
label
Clinical utility of total HCV ...... ect marker of HCV replication.
@en
Clinical utility of total HCV ...... ect marker of HCV replication.
@nl
prefLabel
Clinical utility of total HCV ...... ect marker of HCV replication.
@en
Clinical utility of total HCV ...... ect marker of HCV replication.
@nl
P2093
P356
P1433
P1476
Clinical utility of total HCV ...... ect marker of HCV replication.
@en
P2093
Avidan U Neumann
Christophe Hezode
Daniel Dhumeaux
Gaston Picchio
Harel Dahari
John G McHutchison
Keyur Patel
Lawrence Blatt
Magali Bouvier-Alias
Patrick Larderie
P304
P356
10.1053/JHEP.2002.34130
P407
P577
2002-07-01T00:00:00Z